Biomolecules,
Год журнала:
2025,
Номер
15(4), С. 504 - 504
Опубликована: Март 31, 2025
Growing
evidence
suggests
that
cancer
should
not
be
viewed
solely
as
a
genetic
disease
but
also
the
result
of
functional
defects
in
metaorganism,
including
disturbances
gut
microbiota
(i.e.,
dysbiosis).
The
human
plays
critical
role
regulating
epithelial
barrier
function
gut,
airways,
and
skin,
along
with
host
metabolism
systemic
immune
responses
against
microbes
cancer.
Collaborative
international
networks,
such
ONCOBIOME,
are
essential
advancing
research
equity
building
microbiome
resources
to
identify
validate
microbiota-related
biomarkers
therapies.
In
this
review,
we
explore
intricate
relationship
between
microbiome,
metabolism,
immunity,
propose
microbiota-based
strategies
improve
outcomes
for
individuals
at
risk
developing
or
living
disease.
Journal of Translational Medicine,
Год журнала:
2025,
Номер
23(1)
Опубликована: Янв. 29, 2025
Prostate
cancer
is
one
of
the
most
common
cancers
in
United
States
with
a
high
mortality
rate.
In
recent
years,
traditional
opinion
about
prostate
microbiome
was
challenged.
Although
there
still
are
some
arguments,
an
escalating
number
researchers
shifting
their
focus
toward
within
tumor
environment.
We
mined
data
extracted
from
metagenome,
and
it
offers
broader
taxonomic
coverage
accurate
functional
profiling.
used
Kraken2,
mapping
tool,
to
mine
gut
microbiota
patients.
A
two-sample
Mendelian
Randomization
conducted
reflect
association
between
cancer.
study,
we
found
consistency
special
intratumor
both
non-metastatic
tumors
metastatic
tumors.
And
dig
patients
different
treatments.
that
microbiotas
may
be
associated
progression
exist.
The
anti-androgen
therapy
can
significantly
change
microbiome.
With
metastasis
cancer,
changes.
influences
Our
discovery
help
further
understand
progression,
metastasis,
resistance
perspective
level.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Фев. 6, 2025
Abstract
Despite
advances
in
diagnostic
and
therapeutic
strategies,
the
prognosis
of
lung
squamous
cell
carcinoma
(LUSC)
patients
remains
poor,
potential
microbiome-based
prognostic
biomarkers
targets
largely
unexplored.
LUSC
patient
data
from
The
Cancer
Genome
Atlas
(TCGA),
including
microbial
genus
level
abundance
RNA
sequencing
(RNA-Seq)
data,
were
used
as
a
training
dataset.
Two
other
independent
datasets
GSE19188
GSE157009
serve
validation
datasets.
A
risk
score
(RS)
model
was
constructed
by
univariate
Cox
regression
analysis
combined
with
least
absolute
contraction
selection
operator
(LASSO)
regression.
18
genera
found
to
be
significantly
associated
RFS
patients.
signature
built
these
genera,
exhibited
robust
predictive
accuracy
both
Furthermore,
hub
mRNA
between
high-
low-risk
groups
selected
XGBOOST
intersect
mRNAs
screened
analysis,
finally
identifying
four
prognosis.
This
study
reveals
complex
interplay
microbiome
genetic
biomarkers,
identifies
specific
microbial-based
LUSC.
These
findings
provide
basis
for
future
studies
aimed
elucidate
mechanisms
underlying
associations
guiding
treatment
decisions
improving
outcomes.
Advanced Biology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 6, 2025
Traditional
Chinese
medicine
(TCM)
Yi-Fei-Jie-Du-Tang
(YFJDT)
has
shown
potential
in
lung
cancer
treatment.
However,
the
mechanisms
underlying
effects
of
YFJDT
on
remain
unclear.
Bioinformatics
analysis
is
conducted
to
identify
targets
YFJDT.
The
impact
hypoxia-inducible
factor
1
alpha
(HIF1A),
ferroptosis,
and
vasculogenic
mimicry
(VM)
investigated
using
xenograft
tumor
models
A549
cells.
Additionally,
cells
are
stimulated
with
CoCl2
mimic
hypoxic
microenvironment
tumor.
role
HIF1A
overexpression
modulating
ferroptosis
assessed.
epithelial-mesenchymal
transition
(EMT)
VM
vitro
evaluated.
Results:
treatment
led
a
concentration-dependent
decrease
levels
tumors
Overexpression
counteractes
inhibitory
proliferation,
EMT,
transplanted
tumors.
Moreover,
attenuates
YFJDT-induced
lipid
peroxidation
iron
accumulation,
indicating
inhibition
Hypoxia-induced
alterations
EMT
markers
reversed
by
but
exacerbated
overexpression.
Molecular
docking
identified
salicylic
acid
psoralen
as
components
targeting
HIF1A.
exerts
anti-tumor
downregulating
promoting
ferroptosis.
Journal of Biomedical Science,
Год журнала:
2025,
Номер
32(1)
Опубликована: Фев. 19, 2025
Abstract
Recent
advancements
have
revealed
the
presence
of
a
microbiome
within
tumor
tissues,
underscoring
crucial
role
in
ecosystem.
This
review
delves
into
characteristics
intratumoral
microbiome,
its
dual
modulating
immune
responses
and
potential
to
both
suppress
promote
growth.
We
examine
state-of-the-art
techniques
for
detecting
analyzing
bacteria,
with
particular
focus
on
their
interactions
system
resulting
implications
cancer
prognosis
treatment.
By
elucidating
intricate
crosstalk
between
host
system,
we
aim
uncover
novel
therapeutic
strategies
that
enhance
efficacy
treatments.
Additionally,
this
addresses
existing
challenges
future
prospects
burgeoning
field,
advocating
integration
research
comprehensive
therapy
frameworks.
Graphical
ABSTRACT
Recent
work
has
demonstrated
that
cancer-specific
microbial
communities
often
colonize
tumor
tissues.
However,
untangling
low-biomass
signals
from
environmental
contamination
makes
this
research
technically
challenging.
We
utilize
pseudomyxoma
peritonei
(PMP),
a
cancer
characterized
by
the
spread
of
mucus-secreting
cells
throughout
peritoneal
cavity,
to
develop
robust
workflow
for
identifying
reproducible
microbiomes.
Typically
originating
rupture
an
appendiceal
into
metastasized
tumors
have
been
previously
shown
harbor
core
set
microbes.
did
not
control
potential
these
low
biomass
samples.
expand
upon
prior
findings
characterizing
microbiome
70
additional
PMP
and
six
normal
tissues
along
with
appropriate
laboratory
controls.
Additionally,
DNA
subset
25
was
extracted
sequenced
at
independent
laboratory.
found
evidence
signatures
between
replicates
different
include
taxa
may
be
introduced
surgical
contamination,
as
well
patient-specific
are
also
commonly
implicated
in
colorectal
cancer.
In
addition,
preoperative
chemotherapy
treatment
reduce
diversity.
Our
demonstrate
how
sample
replication
can
powerful
approach
investigate
associated
will
improve
research.
IMPORTANCE
over
30
types
The
origin
their
possible
involvement
carcinogenesis
or
outcomes
remains
unclear,
yet
important
area
A
current
major
challenge
low-biomass,
tumor-associated
microbiomes
is
introduction
during
collection,
handling,
extraction,
PCR,
sequencing.
Here,
we
provide
framework
replicating
samples
help
identify
background
contamination.
Using
approach,
show
(PMP)
host
communities,
including
organisms
Incorporating
future
studies
promising
increase
reproducibility
field.
Cell Reports,
Год журнала:
2025,
Номер
44(3), С. 115358 - 115358
Опубликована: Март 1, 2025
SummaryThe
human
microbiome,
an
intricate
ecosystem
of
trillions
microbes
residing
across
various
body
sites,
significantly
influences
cancer,
a
leading
cause
morbidity
and
mortality
worldwide.
Recent
studies
have
illuminated
the
microbiome's
pivotal
role
in
cancer
development,
either
through
direct
cellular
interactions
or
by
secreting
bioactive
compounds
such
as
metabolites.
Microbial
metabolites
contribute
to
initiation
mechanisms
DNA
damage,
epithelial
barrier
dysfunction,
chronic
inflammation.
Furthermore,
microbial
exert
dual
roles
on
progression
response
therapy
modulating
metabolism,
gene
expression,
signaling
pathways.
Understanding
these
complex
is
vital
for
devising
new
therapeutic
strategies.
This
review
highlights
promising
targets
prevention
treatment,
emphasizing
their
impact
responses
underscoring
need
further
research
into
metastasis
resistance.
Nature Communications,
Год журнала:
2025,
Номер
16(1)
Опубликована: Март 7, 2025
Parvimonas
micra
(P.
micra),
an
opportunistic
oral
pathogen
associated
with
multiple
cancers,
has
limited
research
on
its
role
in
squamous
cell
carcinoma
(OSCC).
This
study
shows
that
P.
is
enriched
OSCC
tissues
and
positively
correlated
tumor
metastasis
stages.
infection
promotes
by
inducing
hypoxia/HIF-1α,
glycolysis,
autophagy.
Mechanistically,
surface
protein
TmpC
binds
to
CKAP4,
a
receptor
overexpressed
OSCC,
facilitating
bacterial
attachment
invasion.
interaction
activates
HIF-1α
autophagy
via
CKAP4-RanBP2
CKAP4-NBR1
pathways,
driving
metastasis.
Targeting
CKAP4
masitinib
or
antibodies
impairs
abolishes
micra-promoted
vitro
vivo.
Together,
our
findings
identify
as
highlight
TmpC-CKAP4
could
be
potential
therapeutic
target
for
OSCC.
micra)
frequently
present
lesions
infections.
Here,
authors
report
regulation
HIF-1α-induced
glycolysis
following
binding
receptor.
Cancer Immunology Immunotherapy,
Год журнала:
2025,
Номер
74(4)
Опубликована: Март 8, 2025
Lower
respiratory
tract
microbiome
constitutes
a
unique
immune
microenvironment
for
advanced
non-small
cell
lung
cancer
as
one
of
dominant
localized
microbial
components.
However,
there
exists
little
knowledge
on
the
associations
between
this
regional
and
clinical
responses
to
anti-PD-1
immunotherapy
from
perspectives.
Here,
we
equivalently
collected
bronchoalveolar
lavage
fluids
56
NSCLC
participants
treated
with
none
(untreated,
n
=
28)
or
(treated,
28),
which
was
further
divided
into
responder
(n
17)
non-responder
11)
subgroups
according
responses,
aiming
compare
their
discrepancy
by
performing
metagenomic
sequencing
targeted
metabolic
alterations
tryptophan
sequencing.
Correspondingly,
diversities
transformed
significantly
after
receiving
immunotherapeutic
agents,
where
Gammaproteobacteria
Campylobacter
enriched,
but
Escherichia,
Streptococcus,
Chlamydia,
Staphylococcus
reduced
at
genus
level,
differences
failed
be
achieved
among
various
(responder
non-responder;
LDA
>
2,
P
<
0.05*).
And
relative
abundance
Streptomyces
escalated
in
response
subgroup
compositional
analysis
(as
≥
3%,
0.05*),
no
significance
untreated
groups.
In
addition,
abundances
bacterial
metabolites
its
derivatives
were
also
higher
subgroup,
distinctively
being
associated
divergent
genera
(VIP
1,
Our
study
revealed
predictive
performance
lower
antitumoral
suggested
that
may
alter
composition
interact
regulate
therapeutic
efficacy
NSCLC,
potential
biomarkers
prognosis
interventional
strategies.
Research Square (Research Square),
Год журнала:
2025,
Номер
unknown
Опубликована: Март 11, 2025
AbstractObjectives
To
elucidate
the
microbial
and
genomic
changes
in
saliva
dental
plaque
during
Oral
Squamous
Cell
Carcinoma
(OSCC)
progression,
to
identify
potential
mechanisms
virulence
factors
involved
OSCC
pathogenesis.
Materials
Methods
Using
metagenomic
sequencing,
64
samples
from
patients
at
different
stages
of
differentiation
were
examined.
Results
The
results
showed
notable
differences
composition
profiles
across
ecological
regions
degrees.
Notably,
relative
abundance
specific
microbes,
such
as
Porphyromonas
gingivalis,
Fusobacterium
nucleatum,
Haemophilus
parainfluenzae,
increased
poorly
differentiated
OSCC.
Microbial
alpha
diversity
correlates
with
tumor
T
staging.
Dental
microbiota
shows
higher
specialization,
especially
tumors.
Both
types
become
more
stable
advanced
Genomic
analysis
reveals
stages.
Subsequently,
functional
pathway
tracing
pathogens
reveal
oral
cancer
may
promote
tumorigenesis
by
secreting
like
GAPDH,
GspG,
AllS,
drive
initiation
progression
through
interactions.
Conclusions
is
associated
altered
composition,
diversity,
plaque.
Poorly
show
factors,
implicating
them
tumorigenesis.
Clinical
Relevance
Understanding
could
help
develop
new
diagnostic
biomarkers
therapies
targeting
microbiota,
potentially
improving
early
detection,
treatment
efficacy,
prognosis
for
patients.
Maintaining
microbiome
homeostasis
also
prevent
cancer.